McNatt; Loretta Graves

Patent Applications and Registrations

Patent applications and USPTO patent grants for McNatt; Loretta Graves.The latest application filed is for "rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma".

Company Profile

0.8.17

McNatt; Loretta Graves - Hurst TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma App 20170073681 - Clark; Abbot F. ; et al.	2017-03-16
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Grant 9,550,994 - Clark , et al. January 24, 2	2017-01-24
Rnai-mediatred Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma App 20150307882 - Clark; Abbot F. ; et al.	2015-10-29
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma App 20150225720 - Clark; Abbot F. ; et al.	2015-08-13
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Grant 9,040,494 - Clark , et al. May 26, 2	2015-05-26
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma App 20140357692 - Clark; Abbot F. ; et al.	2014-12-04
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma App 20130123337 - Clark; Abbot F. ; et al.	2013-05-16
Rnai-mediated Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma App 20120178795 - Clark; Abbot F. ; et al.	2012-07-12
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Grant 8,173,617 - Clark , et al. May 8, 2	2012-05-08
Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents App 20120064532 - CLARK; Abbot F. ; et al.	2012-03-15
Rnai-mediated Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma App 20110190381 - Clark; Abbot F. ; et al.	2011-08-04
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Grant 7,947,660 - Clark , et al. May 24, 2	2011-05-24
Superoxide dismutase-2 expression for glaucoma diagnosis Grant 7,807,363 - Wang , et al. October 5, 2	2010-10-05
Use Of Serum Amyloid A Gene In Diagnosis And Treatment Of Glaucoma And Identification Of Anti-glaucoma Agents App 20100063052 - Clark; Abbot F. ; et al.	2010-03-11
Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents Grant 7,662,389 - Clark , et al. February 16, 2	2010-02-16
Inhibitors Of Glycogen Synthase Kinase-3 (gsk-3) For Treating Glaucoma App 20090312390 - Hellberg; Mark R. ; et al.	2009-12-17
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma Grant 7,598,288 - Hellberg , et al. October 6, 2	2009-10-06
Superoxide Dismutase-2 Expression And Modulation For Glaucoma Diagnosis And Therapy App 20080085878 - WANG; Wan-Heng ; et al.	2008-04-10
Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents App 20070208043 - Clark; Abbot F. ; et al.	2007-09-06
RNAi-mediated inhibition of Frizzled Related Protein-1 for treatment of glaucoma App 20060223773 - Clark; Abbot F. ; et al.	2006-10-05
Method of reducing intraocular pressure and treating glaucoma App 20060154981 - Klimko; Peter G. ; et al.	2006-07-13
Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway App 20050170430 - Clark, Abbot F ; et al.	2005-08-04
Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/planar cell polarity (pcp) signaling pathway App 20050164907 - Clark, Abbot F ; et al.	2005-07-28
Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma App 20040186159 - Hellberg, Mark R. ; et al.	2004-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.